(4-tert-Butyl-isoxazol-3-yl)-methyl-amine, 95.0%, 1g

2-Nitrobenzaldehyde, min. 98%, for synthesis, 250 g, plastic packaging.

1-(3-chloro-4-methoxyphenyl)-3-(ethoxycarbonyl)-5-methyl-4,5-dihydro-1H-pyrazole-5-carboxylic acid, 95.0%, 5g

3-Cyclohexenecarbonitrile, 98.0%, 10g

Dimethyl Decahydro-1,4-naphthalenedicarboxylate (mixture of isomers)>97.0%(GC)1g

phenyl(4-phenylpiperazin-1-yl)acetic acid, 1g

1'H-SPIRO[CYCLOHEXANE-1,2'-QUINAZOLIN]-4'(3'H)-ONE, 95.0%, 250mg

N2-Acetyl acyclovir, 98%, 250mg

1-(5-Bromopyridin-2-yl)piperidin-4-ol, 95+%, 5g

5-(3-Trifluoromethyl-phenyl)-furan-2-carbaldehyde, 97.0%, 1g

Ethyl 5-methylindole-2-carboxylate, 95.0%, 10g

Bisindolylmaleimide I>97.0%(HPLC)25mg

2-(Trifluoromethyl)pyrazine, 98.0%, 25g